NCT00801125View on ClinicalTrials.gov

Study of Tysabri (Natalizumab) in Patients Who Failed Anti-TNF-α Therapy

PHASE4WithdrawnINTERVENTIONAL

0

Timeline

Start Date

December 31, 2008

Primary Completion Date

May 31, 2010

Conditions

Crohn's Disease

Interventions

DRUG

natalizumab

Sponsors

Lead Sponsor

Collaborators (1)

Elan Pharmaceuticals

All Listed Sponsors

collaborator

Elan Pharmaceuticals

INDUSTRY

lead

Biogen

INDUSTRY